| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | — | — | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | — | — | — |
| Net Income | $0.7B | $0.3B | $0.4B |
| EPS (Basic) | $1.80 | $1.52 | $1.80 |
| EPS (Diluted) | $1.80 | $1.52 | $1.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $14.7B | $6.7B | $6.7B |
| Current Assets | — | — | — |
| Cash & Equivalents | — | — | $0.5B |
| Total Liabilities | $6.7B | $3.1B | $3.1B |
| Current Liabilities | — | — | — |
| Stockholders' Equity | $8.0B | $3.6B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $-0.9B | $0.1B | $0.7B |
| Investing Cash Flow | — | — | — |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $0.9B | $-0.3B | $-0.4B |